CYP2C19 polymorphism and proton pump inhibitors

Basic & Clinical Pharmacology & Toxicology
U KlotzGerhard Treiber

Abstract

Proton pump inhibitors such as omeprazole (esomeprazole), lansoprazole, pantoprazole and rabeprazole are eliminated by the hepatic route and the polymorphic CYP2C19 is mainly involved in their metabolism. In different populations three phenotypes have been identified: extensive metabolizers, poor metabolizers and individuals carrying one wild type and one mutant allele (het extensive metabolizers). Systemic exposure to the proton pump inhibitors as expressed by the AUC (area under the plasma level time profiles) is 5-12-times higher in poor metabolizers than in extensive metabolizers. As the pharmacodynamic response (elevation of intragastric pH) to the proton pump inhibitors is related directly to their AUC, a much higher pH can be monitored over 24 hr in poor metabolizers than in extensive metabolizers. Furthermore, clinical efficacy of all proton pump inhibitors depend on maintaining intragastric pH above certain threshold levels and significantly higher eradication rates of Helicobacter pylori have been observed in patients of the poor metabolizers and het extensive metabolizers phenotype if compared to extensive metabolizers. Likewise, limited data suggest that proton pump inhibitors-induced healing rates in gastro-oesopha...Continue Reading

References

Jun 21, 1997·BMJ : British Medical Journal·P S SchönhöferU Tröger
Aug 1, 1997·Clinical Pharmacology and Therapeutics·G TybringL Bertilsson
May 26, 1999·Clinical Pharmacology and Therapeutics·T FurutaT Ishizaki
Sep 24, 1999·Alimentary Pharmacology & Therapeutics·T Ishizaki, Y Horai
Dec 1, 1999·Clinical Pharmacology and Therapeutics·Y TanigawaraK Okumura
Nov 1, 2001·Alimentary Pharmacology & Therapeutics·Y HoraiT Ishizaki
Nov 17, 2001·JAMA : the Journal of the American Medical Association·K A PhillipsW Sadee
Dec 12, 2001·Alimentary Pharmacology & Therapeutics·N ShiraiT Ishizaki
Jan 12, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M DojoM Kuriyama
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN European Helicobacter Pylori Study Group (EHPSG)
Mar 21, 2002·Pharmacology & Toxicology·D Gillen, K E McColl
Aug 2, 2002·Clinical Pharmacology and Therapeutics·Kyoung-Ah KimJae-Gook Shin
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Oct 19, 2002·Clinical Pharmacology and Therapeutics·Takahisa FurutaHiroyuki Hanai
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Mar 4, 2003·Biological & Pharmaceutical Bulletin·Tomoko KitaKatsuhiko Okumura
Mar 27, 2003·Alimentary Pharmacology & Therapeutics·M KawamuraUNKNOWN Study Group of GERD
Apr 12, 2003·Pharmacotherapy·Elaine Chong, Mary H H Ensom
May 21, 2003·Alimentary Pharmacology & Therapeutics·R M KlokJ R B J Brouwers
Jun 18, 2003·The American Journal of Gastroenterology·A SaponeM Paolini
Jul 10, 2003·Gastroenterology·Raymond C Givens, Paul B Watkins
Sep 27, 2003·Toxicology·Munir Pirmohamed, B Kevin Park
Oct 25, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Euan J Dickson, Robert C Stuart
Dec 23, 2003·Der Internist·U KlotzE Mutschler

❮ Previous
Next ❯

Citations

Jul 16, 2005·European Journal of Clinical Pharmacology·Jørgen G BramnessJørg Mørland
Aug 6, 2008·European Journal of Clinical Pharmacology·Shaojun Shi, Ulrich Klotz
Oct 30, 2008·European Journal of Clinical Pharmacology·Ulrich Klotz
Oct 18, 2008·European Journal of Clinical Pharmacology·Julia KirchheinerJürgen Brockmöller
Jun 3, 2006·Epidemiology and Infection·T SuzukiK Tajima
Feb 9, 2012·Nature Reviews. Gastroenterology & Hepatology·Michael Camilleri
Feb 16, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N YamamotoN Boku
Aug 13, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Rashmi R Shah
Apr 14, 2010·Journal of Veterinary Internal Medicine·G W SmithD M Foster
Jun 1, 2012·Clinical and Experimental Gastroenterology·Mitsushige Sugimoto, Takahisa Furuta
Nov 22, 2005·Pharmacogenomics·Yingying GuoGary Peltz
Jan 26, 2013·Journal of Neurogastroenterology and Motility·Jai Moo Shin, Nayoung Kim
Mar 19, 2014·Drugs & Aging·Gwen M C MascleeErnst J Kuipers
Nov 26, 2005·Expert Review of Anti-infective Therapy·Ala I Sharara
Oct 6, 2006·Expert Opinion on Pharmacotherapy·Yuri A Saito, Michael Camilleri
Jun 28, 2013·Expert Opinion on Drug Metabolism & Toxicology·Nicola de BortoliEdoardo Savarino
Jun 12, 2009·Drug Metabolism Reviews·Ulrich Klotz
Feb 3, 2007·Expert Opinion on Pharmacotherapy·Gerhard TreiberUlrich Klotz
Dec 9, 2009·Expert Opinion on Drug Metabolism & Toxicology·Jyh-Chin Yang, Chun-Jung Lin
Oct 26, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Kyung-Ah SeoJae-Gook Shin
Oct 1, 2013·Clinical Pharmacology in Drug Development·Kevin M KochDerry Ridgway
Jun 19, 2013·The Kaohsiung Journal of Medical Sciences·Meng-Kwan LiuJyh-Jou Chen
Dec 15, 2015·Alimentary Pharmacology & Therapeutics·E Gómez-TorrijosJ Molina-Infante
Mar 9, 2010·Life Sciences·Jessica MwinyiMagnus Ingelman-Sundberg
Nov 21, 2009·The Lancet Infectious Diseases·Reinhold KerbMatthias Schwab
Feb 5, 2010·Journal of Bioscience and Bioengineering·Harumi GinyaMasafumi Yohda
Jan 9, 2007·Psychosomatics·Gary H WynnKelly L Cozza
May 6, 2011·Thrombosis and Haemostasis·H FernandoJ A Shaw
Jul 13, 2004·Basic & Clinical Pharmacology & Toxicology·Leif Bertilsson
Jun 9, 2005·Pharmazie in unserer Zeit·Ulrich Klotz
Aug 8, 2015·The Journal of Antimicrobial Chemotherapy·Sarah DraegerErik-Oliver Glocker
Jul 17, 2010·Helicobacter·Chao-Hung KuoDeng-Chyang Wu
Feb 5, 2010·Journal of Thrombosis and Haemostasis : JTH·C S ZuernT Geisler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.